Shopping Cart 0
Cart Subtotal
USD 0

Implantable Infusion Pumps - Medical Devices Pipeline Assessment, 2018

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 5000

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 7500
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, Implantable Infusion Pumps-Medical Devices Pipeline Assessment, 2018 provides an overview of Implantable Infusion Pumps currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Implantable Infusion Pumps pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Implantable Infusion Pumps under development

- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities

- The report reviews the major players involved in the development of Implantable Infusion Pumps and list all their pipeline projects

- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage

- The report provides key clinical trial data of ongoing trials specific to pipeline products

- Recent developments in the segment / industry

Reasons to buy

The report enables you to-

- Formulate significant competitor information, analysis, and insights to improve R&D strategies

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Identify and understand important and diverse types of Implantable Infusion Pumps under development

- Develop market-entry and market expansion strategies

- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline

- In-depth analysis of the product's current stage of development, territory and estimated launch date

READ MORE

Table Of Content

Scope

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 3

1.2 List of Figures 3

2 Introduction 4

2.1 Implantable Infusion Pumps Overview 4

3 Products under Development 5

3.1 Implantable Infusion Pumps-Pipeline Products by Stage of Development 5

3.2 Implantable Infusion Pumps-Pipeline Products by Territory 6

3.3 Implantable Infusion Pumps-Pipeline Products by Regulatory Path 7

3.4 Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 8

3.5 Implantable Infusion Pumps-Ongoing Clinical Trials 9

4 Implantable Infusion Pumps-Pipeline Products under Development by Companies 10

4.1 Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 10

4.2 Implantable Infusion Pumps-Pipeline Products by Stage of Development 11

5 Implantable Infusion Pumps Companies and Product Overview 12

5.1 Debiotech SA Company Overview 12

5.1.1 Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 12

5.2 Eksigent Technologies LLC Company Overview 13

5.2.1 Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

5.3 Eli Lilly and Co Company Overview 14

5.3.1 Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 14

5.4 Flowonix Medical Inc Company Overview 15

5.4.1 Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 15

5.5 Intarcia Therapeutics Inc Company Overview 19

5.5.1 Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

5.6 Massachusetts Institute of Technology Company Overview 21

5.6.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 21

5.7 Medtronic plc Company Overview 23

5.7.1 Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 23

5.8 University of Minnesota Company Overview 24

5.8.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 24

5.9 University of Southern California Company Overview 25

5.9.1 University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 25

6 Implantable Infusion Pumps- Recent Developments 26

6.1 Jan 11, 2018: New Study Shows Superiority of Intrathecal Baclofen Therapy Over Oral Medication for the Treatment of Severe Post-Stroke Spasticity 26

6.2 Oct 02, 2017: Flowonix Medical and Cerebral Therapeutics Announce Fifth Implant of First-of-a-Kind Implantable Drug Therapy to Treat Patients with Refractory Epilepsy 27

6.3 Sep 27, 2017: Intarcia Provides Corporate Update 28

6.4 Sep 15, 2017: New Intarcia Study Evaluates Optimal Way to Switch from Daily Liraglutide Injections to ITCA 650 in Patients with Type 2 Diabetes 28

7 Appendix 30

7.1 Methodology 30

7.2 About GlobalData 33

7.3 Contact Us 33

7.4 Disclaimer 33


List Of Figure

1.2 List of Figures

Figure 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 5

Figure 2: Implantable Infusion Pumps-Pipeline Products by Territory 6

Figure 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 7

Figure 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 8

Figure 5: Implantable Infusion Pumps-Ongoing Clinical Trials 9


List Of Table

1.1 List of Tables

Table 1: Implantable Infusion Pumps-Pipeline Products by Stage of Development 5

Table 2: Implantable Infusion Pumps-Pipeline Products by Territory 6

Table 3: Implantable Infusion Pumps-Pipeline Products by Regulatory Path 7

Table 4: Implantable Infusion Pumps-Pipeline Products by Estimated Approval Date 8

Table 5: Implantable Infusion Pumps-Ongoing Clinical Trials 9

Table 6: Implantable Infusion Pumps Companies-Pipeline Products by Stage of Development 10

Table 7: Implantable Infusion Pumps-Pipeline Products by Stage of Development 11

Table 8: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 12

Table 9: MIP Implantable Pump-Product Status 12

Table 10: MIP Implantable Pump-Product Description 12

Table 11: Eksigent Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 13

Table 12: Implantable Drug Delivery System-Product Status 13

Table 13: Implantable Drug Delivery System-Product Description 13

Table 14: Eli Lilly and Co Pipeline Products & Ongoing Clinical Trials Overview 14

Table 15: Drug Delivery System-Parkinson's Disease-Product Status 14

Table 16: Drug Delivery System-Parkinson's Disease-Product Description 14

Table 17: Flowonix Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 15

Table 18: Implanted Drug Delivery System-Product Status 15

Table 19: Implanted Drug Delivery System-Product Description 15

Table 20: Prometra II Programmable Infusion System-ICV-Product Status 16

Table 21: Prometra II Programmable Infusion System-ICV-Product Description 16

Table 22: Flowonix Medical Inc-Ongoing Clinical Trials Overview 17

Table 23: Prometra II Programmable Infusion System-ICV-A Dose Ranging Pilot Study to Assess Intracerebroventricular (ICV) Delivery of Valproate in Subjects with Focal Seizures, with Temporal Lobe Onset with or without Secondary Generalization 18

Table 24: Intarcia Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 19

Table 25: ITCA 650 Osmotic Pump-Product Status 19

Table 26: ITCA 650 Osmotic Pump-Product Description 19

Table 27: Omega DUROS-Product Status 20

Table 28: Omega DUROS-Product Description 20

Table 29: Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 21

Table 30: Implantable Micro-Cannula Device-Product Status 21

Table 31: Implantable Micro-Cannula Device-Product Description 21

Table 32: MiNDS-Product Status 22

Table 33: MiNDS-Product Description 22

Table 34: Medtronic plc Pipeline Products & Ongoing Clinical Trials Overview 23

Table 35: ALN-HTT Infusion System-Product Status 23

Table 36: ALN-HTT Infusion System-Product Description 23

Table 37: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 24

Table 38: Infusion Micropump-Product Status 24

Table 39: Infusion Micropump-Product Description 24

Table 40: University of Southern California Pipeline Products & Ongoing Clinical Trials Overview 25

Table 41: Drug Infusion Pump-Product Status 25

Table 42: Drug Infusion Pump-Product Description 25

Table 43: Glossary 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Debiotech SA, MIP Implantable Pump; Eksigent Technologies LLC, Implantable Drug Delivery System; Eli Lilly and Co, Drug Delivery System - Parkinson's Disease; Flowonix Medical Inc, Implanted Drug Delivery System; Flowonix Medical Inc, Prometra II Programmable Infusion System - ICV; Intarcia Therapeutics Inc, ITCA 650 Osmotic Pump; Intarcia Therapeutics Inc, Omega DUROS; Massachusetts Institute of Technology, Implantable Micro - Cannula Device; Massachusetts Institute of Technology, MiNDS; Medtronic plc, ALN-HTT Infusion System; University of Minnesota, Infusion Micropump; University of Southern California, Drug Infusion Pump


Companies

Debiotech SA

Eksigent Technologies LLC

Eli Lilly and Co

Flowonix Medical Inc

Intarcia Therapeutics Inc

Massachusetts Institute of Technology

Medtronic plc

University of Minnesota

University of Southern California